Scientists are opening a new front in the war on cancer with plans to develop "anti-evolution" drugs to stop tumor cells from developing resistance to treatment.
Britain's Institute of Cancer Research (ICR), one of the world's top cancer centers, said on Friday its initiative was the first to have at its heart the target of overcoming cancer evolution and drug resistance.
In the same way that bacteria evolve resistance to antibiotics, cancer cells also change to evade the medicines used to fight them, leading to "survival of the nastiest."